Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis
Vicki Wing‐Ki Hui, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100814-100814
Open Access | Times Cited: 11

Showing 11 citing articles:

Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B
Terry Cheuk‐Fung Yip, Jimmy Che‐To Lai, Tsz‐Fai Yam, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 4, pp. 553-563
Closed Access | Times Cited: 23
Recompensation after TIPS reduces the incidence of hepatocellular carcinoma and increases survival in patients with cirrhosis
José Luis Alfonso Sánchez, Sheila González, Paloma Poyatos, et al.
Liver International (2024)
Open Access | Times Cited: 6
Recompensation of decompensated cirrhosis in hepatitis C patients after SVR: Prognostic implications
Yolanda Sánchez‐Torrijos, Paula Álvarez, José Miguel Rosales Zábal, et al.
Journal of Hepatology (2025)
Closed Access
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis
Federico Piñero, Margarita Anders, Carla Bermúdez, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Recompensation in Cirrhosis: Biomarkers and Strategies
Wagner Ramírez-Quesada, Edilmar Alvarado‐Tápias, Sarah Shalaby, et al.
Seminars in Liver Disease (2025)
Closed Access
Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease
Marta Tonon, Roberta Gagliardi, Enrico Pompili, et al.
Journal of Hepatology (2025)
Closed Access
Advancing our understanding of recompensated cirrhosis - the new “holy grail” of decompensated cirrhosis
Thomas Reiberger, Benjamin Maasoumy
Journal of Hepatology (2025)
Closed Access
Pharmacologic Treatment of Portal Hypertension
Yu Jun Wong, Juan G. Abraldeṣ
Clinics in Liver Disease (2024) Vol. 28, Iss. 3, pp. 417-435
Closed Access | Times Cited: 2
Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria
Yiheng Zhang, Xu Liu, Shu Li, et al.
Hepatology Communications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Portal hypertension: Advances in clinical practice from the Baveno VII consensus statement
Hitoshi Yoshiji
Kanzo (2024) Vol. 65, Iss. 2, pp. 49-57
Open Access | Times Cited: 1
Mechanisms and implications of recompensation in cirrhosis
Salvatore Piano, Thomas Reiberger, Jackie Bosch
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101233-101233
Open Access | Times Cited: 1
Prevention of Decompensation in Compensated Cirrhosis: Non-Selective Beta-Blockers for Everyone?
Sanchit Sharma, Dhiraj Tripathi
EMJ Hepatology (2024), pp. 74-80
Open Access
Liver cirrhosis reversal and recompensation: Existing evidence and future prospects
Tao Du, Bing Yu, Wei Luo
Shijie huaren xiaohua zazhi (2024) Vol. 32, Iss. 5, pp. 320-326
Open Access
Alcohol-related liver disease: (Re)compensation of abstinence
Joaquín Cabezas, José Ignacio Fortea, Ángela Puente Sánchez, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 10, pp. 502263-502263
Closed Access
Page 1

Scroll to top